• 제목/요약/키워드: nondiabetic

검색결과 39건 처리시간 0.025초

Anti-Diabetic Effect of Red Ginseng-Chungkukjang with Green Laver or Sea Tangle

  • Kim, Mee-Jung;Kim, Song-Suk;Kim, Soon-Dong
    • Preventive Nutrition and Food Science
    • /
    • 제15권3호
    • /
    • pp.176-183
    • /
    • 2010
  • The hypoglycemic effects of red ginsgeng-chungkukjang plus seaweeds, green laver and sea tangle, in streptozotocin (STZ)-induced diabetic rats were investigated. Five groups of male Sprague-Dawley rats weighing $140\pm10$ g (10 animals/group) were fed for four weeks with the following: nondiabetic control (NC group); STZ-induced diabetic (D group); diabetic rats fed 3% red ginseng (20%, w/w)-chungkukjang (D-RC group); diabetic rats fed RC containing 10% (w/w) green laver powder (D-RCG group); diabetic rats fed RC containing 10% (w/w) sea tangle powder (D-RCS group). Partially normalized body weight gain, FER, and blood glucose levels were observed in the D-RC, D-RCG and D-RCS groups as compared to the D group. In these three groups, serum levels of triglycerides, total cholesterol, and LDL-cholesterol were found to be lower than in the D group, whereas HDL-cholesterol levels increased. Serum insulin level in D was significantly lower than that of NC, although D-RC, D-RCG, and D-RCS almost recovered to the NC. Serum ALT activity was markedly increased in the D group, while the serum ALT levels in the D-RC, D-RCG, and D-RCS were almost the same as the NC group. Due to diabetes, hepatic xanthine oxidase (XO) activity was significantly increased and administration of red ginseng-chungkukjang or seaweeds resulted in decreased levels of the XO activity. Activity of hepatic antioxidant enzymes (superoxide dismutase and glutathione peroxidase) were significantly decreased in the D group, but the activity in the D-RC, D-RCG, and D-RCS groups were similar to that of the NC group. Results of the present study indicate that supplementation of red ginseng-chungkukjang with seaweed after the onset of diabetes ameliorated hyperglycemia via an increase in serum insulin.

Nutritional status and the role of diabetes mellitus in hemodialysis patients

  • Cho, Ju-Hyun;Hwang, Ji-Yun;Lee, Sang-Eun;Jang, Sang-Pil;Kim, Wha-Young
    • Nutrition Research and Practice
    • /
    • 제2권4호
    • /
    • pp.301-307
    • /
    • 2008
  • This study was aimed to investigate the nutritional status and the role of diabetes mellitus in hemodialysis (HD) patients. Anthropometric, biochemical, and dietary assessments for HD 110 patients (46 males and 64 females) were conducted. Mean body mass index (BMI) was $22.1\;kg/m^2$ and prevalence of underweight (BMI<$18.5\;kg/m^2$) was 12%. The hypoalbuminemia (<3.5 g/dl) was found in 15.5% of the subject, and hypocholesterolemia (<150 mg/dl) in 46.4%. About half (50.9%) patients had anemia (hemoglobin: <11.0 g/dL). High prevalence of hyperphosphatemia (66.4%) and hyperkalemia (43.5%) was also observed. More than 60 percent of subjects were below the recommended intake levels of energy (30-35 kcal/kg IBW) and protein (1.2 g/kg IBW). The proportions of subjects taking less than estimated average requirements for calcium, vitamin $B_1$, vitamin $B_2$, vitamin C, and folate were more than 50%, whereas, about 20% of the subjects were above the recommended intake of phosphorus and potassium. Diabetes mellitus was the main cause of ESRD (45.5%). The diabetic ESRD patients showed higher HMI and less HD adequacy than nondiabetic patients. Diabetic patients also showed lower HDL-cholesterol levels. Diabetic ESRD patients had less energy from fat and a greater percentage of calories from carbohydrates. In conclusion, active nutrition monitoring is needed to improve the nutritional status of HD patients. A follow-up study is needed to document a causal relation between diabetes and its impact on morbidity and mortality in ESRD patients.

Diabetic Atherosclerosis and Glycation of LDL(Low Density Lipoprotein)

  • Park, Young-June;Kim, Tae-Woong
    • Preventive Nutrition and Food Science
    • /
    • 제1권1호
    • /
    • pp.134-142
    • /
    • 1996
  • Diabetes carries an increased risk of atherosclerotic disease that is not fully explained by known car-diovascular risk factors. There is accumulating evidence that advanced glycation of structural proteins, and oxidation and glycation of circulating lipoproteins, are implicated in the pathogenesis of diabetic ather-osclerosis. Reactions involving glycation and oxidation of proteins and lipids are believed to contribute to atherogenesis. Glycation, the nonenzymatic binding of glucose to protein molecules, can increase the ather-ogenic potential of certain plasma constituents, including low density lipoptotein(LDL). Glycation of LDL is significant increased in diabetic patients compared with normal subjects, even in the presence of good glycemic control. Metabolic abnormalities associated with glycation of LDL include diminished recognition of LDL by the classic LDL receptor; increased covalent binding of LDL in vessel walls ; enhanced uptake of LDL by the macrophages, thus stimulating foam cell formation ; increased platelet aggregation; formation of LDL-immune complexes ; and generation of oxygen free radicals, resulting on oxidative damage to both the lipid and protein components of LDL and to any nearby macromolecules. Oxidized lipoproteins are characterzied by cytotoxicity, potent stimulation of foam cell formation by macrophages, and procoagulant effects. Combined glycation and oxidation, "glycoxidation" occurs when oxidative reactions affect the initial products of glycation, and results in irreversible structural alterations of proteins. Glycoxidation is of greatest significance in long lived proteins such as collagen. In these proteins, glycoxidation products, believed to be atherogenic, accumulate with advancing age : in diabetes, their rate of accumulate is accelerated. Inhibition of glycation, oxidation and glycoxidation may form the basis of future antiaterogenic strategies in both diabetic and nondiabetic individuals.dividuals.

  • PDF

Family history of chronic renal failure is associated with malnutrition in Korean hemodialysis patients

  • Hwang, Ji-Yun;Cho, Ju-Hyun;Lee, Yoon-Jung;Jang, Sang-Pil;Kim, Wha-Young
    • Nutrition Research and Practice
    • /
    • 제3권3호
    • /
    • pp.247-252
    • /
    • 2009
  • The present study was to investigate the nutritional status and factors related to malnutrition in end-stage renal disease (ESRD) patients requiring hemodialysis (HD) in South Korea. Subjects were ESRD outpatients from general hospitals or HD centers in Seoul referred to the dialysis clinic for maintenance HD care. A total of 110 patients (46 men and 64 women; mean ages $58.6{\pm}1.0y$) were eligible for this study. The family history of chronic renal failure (CRF) was considered positive if a patient reported having either a first-degree or second-degree relative with CRF. Malnutrition was defined as a triceps skinfold thickness or mid-ann muscle circumference below the fifth percentile for age and sex and forty-seven of the 110 patients were malnourished. Almost all (94%) patients had anemia (hemoglobin: <13 g/dL for men and <12 g/dL for women). Energy intake was below the recommended intake levels of energy [30-35 kcal/kg ideal body weight (IBW)] and protein (1.2 g/kg IBW) in 60% of patients. The duration of HD was longer in malnourished HD patients (P=0.0095). Malnutrition was more prevalent in women (P=0.0014), those who never smoked (P=0.0007), nondiabetic patients (P=0.0113), and patients with bone diseases (P=0.0427), adequate HD (spKt/$V{\geq}1.2$) (P=0.0178), and those with a family history of CRF (P=0.0255). Multiple logistic regression was used to examine the relationship between malnutrition and potential risk factors. After adjusting for age, sex, and other putative risk factors for malnutrition, the OR for malnutrition was greater in HD patients with a family history of CRF (OR, 3.290; 95% CI, $1.003{sim}10.793$). Active nutrition monitoring is needed to improve the nutritional status of HD patients. A family history of CRF may be an independent risk factor for malnutrition in Korean HD patients. A follow-up study is needed to investigate whether there is a causal relationship between a family history of CRF and malnutrition in Korean ESRD patients.

Protein Tyrosine Phosphatase N1 Gene Variants Associated with Type 2 Diabetes Mellitus and Its Related Phenotypes in the Korean Population

  • Hong, Kyung-Won;Jin, Hyun-Seok;Lim, Ji-Eun;Ryu, Ha-Jung;Ahn, Youn-Jhin;Lee, Jong-Young;Han, Bok-Ghee;Shin, Hyoung-Doo;Cho, Nam-Han;Shin, Chol;Woo, Jeong-Taek;Park, Hun-Kuk;Oh, Berm-Seok
    • Genomics & Informatics
    • /
    • 제6권3호
    • /
    • pp.99-109
    • /
    • 2008
  • Protein phosphorylation at tyrosine residues is a key regulatory event that modulates insulin signal transduction. We studied the PTPN1 gene with regard to susceptibility to Korean type 2 diabetes mellitus (T2DM) and its related quantitative traits. A total of seven SNPs [g.36171G>A (rs941798), g.58166G>A (rs3787343), g.58208A>G (rs2909270), g.64840C>T (rs754118), g.69560C>G (rs6020612), g.69866G>A (rs718050), and g.69934T>G (rs3787343)] were selected based on frequency (>0.05), linkage disequilibrium (LD) status, and haplotype tagging status. We studied the seven SNPs in 483 unrelated patients with type 2 diabetes (age: $64{\pm}2.8$ years, onset age: $56{\pm}8.1$ years; 206 men, 277 women) and 1138 nondiabetic control subjects (age: $64{\pm}2.9$; 516 men, 622 women). The SNP rs941798 had protective effects against T2DM with an odds ratio of 0.726 (C.I. $0.541{\sim}0.975$) and p-value=0.034, but none of the remaining six SNPs was associated with T2DM. Also, rs941798 was associated with blood pressure, HDL cholesterol, insulin sensitivity. rs941798 also has been associated with T2DM in previous reports of Caucasian-American and Hispanic-American populations. This is the first report that shows an association between PTPN1 and T2DM in the Korean as well as Asian population.

당뇨병 환자에서 우식경험영구치지수, 치주질환지수 및 구강위생 상태 (DMFT Index, Periodontal Index and Oral Hygiene Status in Diabetic Patients)

  • 이경동;이희경
    • Journal of Yeungnam Medical Science
    • /
    • 제22권1호
    • /
    • pp.62-71
    • /
    • 2005
  • 본 연구는 당뇨병 환자의 구강건강상태를 파악하고 이를 근거로 당뇨병 환자의 구강건강에 대한 인식과 교육의 필요성을 확인하여 당뇨병의 적절한 관리를 위한 프로그램 개발의 기초자료를 마련하고자 하였다. 대구광역시 달성군 지역의 일개 보건 진료소에서 당뇨병 환자 및 내당능 장애로 진단되어 관리하고 있는 50명을 환자군으로 먼저 선정하였고 대조군은 환자군의 연령과 성비를 고려하여 같은 지역에서 당뇨병 환자가 아닌 50명을 대상으로 구강 검사와 설문조사를 실시하여 다음과 같은 결과를 얻었다. 첫째, 당뇨병 환자군과 대조군의 평균우식경 험영구치지수(DMFT index)는 각각 $18.10{\pm}8.34$, $14.54{\pm}7.98$로 당뇨병 환자군에서 유의하게 높게 나타났다(p<0.05). 우식치지수와 충전치지수는 두 군간의 유의성이 나타나지 않았으나 상실치지수는 당뇨병 환자군에서 대조군보다 유의하게 높게 나타났다. 둘째, 당뇨병 환자군과 대조군의 평균 치주질환지수(PI)는 각각 $3.48{\pm}0.95$, $2.90{\pm}0.93$으로 당뇨병 환자군에서 대조군보다 유의하게 높게 나타났다(p<0.01). 연령대별로 보면 50대와 60대에서는 당뇨병 환자군이 대조군보다 유의하게 높게 나타났으나 (p<0.01, p<0.05), 70대에서는 두군간의 차이는 유의하지 않았다. 셋째, 구강위생상태는 두 군간의 유의한 차이가 나타나지 않았다. 넷째, 당뇨병 환자군과 대조군의 평균 잔존치아수는 각각 $16.1{\pm}10.35$, $20.04{\pm}8.70$으로 대조군에서 유의하게 높게 나타났다(p<0.05). 이 결과로 볼 때 당뇨병 환자군에서 평균우식경험영구치지수(DMFT index), 상실치지수(MT index), 치주질환지수(PI)가 높게 나타났으며, 평균잔존치아수가 낮은 것으로 나타났다. 본 연구는 당뇨병 환자의 구강상태를 파악함으로 당뇨병 환자의 구강 건강 증진을 위한 프로그램을 개발하는데 기초가 될 수 있을 것이다.

  • PDF

당뇨병(糖尿病) 환자(患者)에 병발(倂發)된 뇌졸중(腦卒中)의 임상적(臨床的) 고찰(考察) (Clinical Observation on C.V.A with Diabetes Mellitus)

  • 윤철호;서운교;정지천
    • 대한한방내과학회지
    • /
    • 제15권1호
    • /
    • pp.22-44
    • /
    • 1994
  • Clinical observations were done on 67 cases with Diabetes Mellitus in CVA patients who were confirmed by CT scan and observed for over 1 week, admitted to the Dept. of Internal Medicine in Oriental Medical Hospital of Dongguk University from January 1992 to December 1993. The results were as follows; 1. 86 patients (15.3%) with Diabetes Mellitus were found in 561 CVA patients, the 6th decade of age was 40.2%, the ratio of male to female was 0.72:1. 2. The local distribution of CVA was similar to common CVA, and occlusive CVD was 83.6%, cerebral hemorrhage was 16.4% in this study. 3. The association between blood glucose and years were not significant. The largest ratio of fasting blood glucose were 140-199 mg/dl (44.6%) in admission, below 139 mg/dl (51.8%) in discharge in case of occlusive CVD. In cerebral hemorrhage, that were 140-199 mg/dl(45.5%) in dmission, below 139 mg/dl (45.5%) in discharge. The largest ratio of pp2hrs blood glucose were 200-299mg/dl in admission and discharge both occlusive CVD and cerebral hemorrhage. 4. The total sensitivity of urine glucose was 71.6%, and sensitivity of urine glucose in cerebral hemorrhage (81.8%) was more higher than that of occlusive CVD (69.6%). 5. Below 4 years had the highest prevalence(44.8%) in duration of diabetes mellitus. Patients usually used oral hypoglycemic agents(41.8%), insulin injection(23.9%) treatment and non-therapeutic was 17.9% in this study. 6. Predisposing factors and symptoms in admissin were similar to common CVA. The conscious disturbance on attacck was 41.1% in occlusive CVD, and that was 63.7% in cerebral hemorrhage. 7. The most common ratio of the season's attack was spring (44.8%), 8. The frequency of post history was as follows, hypertension (44.8%), heart disease (10.4%), and they were in below 199 mg/dl (83.3%) of fasting blood glucose. 9. The family history of CVA was 46.3%, and they was higher than nondiabetic patients. 10. The recurrence rate of CVA was 28.4%, and that of occlusive CVD(28.6%) was higer than cerebral hemorrhage's (18.2%). 11. The smoker was 52.2%, the drinker was 38.9%. 12. The complications was occured in 10 cases (14.9%) after admission, and they frequently occured than common CVA. 13. In admission, the ratio of systolic blood pressure in over l60mmHg was 42.9%, that of diastolic blood pressure in over l00mmHg was 12.5% in occlusive CVD. In cerebral hemorrhage, the ratio of systolic blood pressure in over l60mmHg was 54.5%, that of diastolic blood pressure in over l00mmHg was 27.3%. 14. The average beginned time of physical theraphy was, generally lated, 8.3 days in occlusive CVD, 11.2 days in cerebral hemorrhage. Average admitted period was longer than common CVA, and was 29.2 days in occlusive CVD, 11.2 days in cerebral hemorrhage. 15. The degree of recovery were 82.1% in occlusive CVD, 72.7% in cerebral hemorrhage. 16. The herb medications were various Sunghyanggeonggisans, Sopungtang, Ganghwalyupungtang, Yanggyuksan etc. were used most frequently, and Yukmijihwangtang, Gamidaebotang, Mangeumtang etc. were used as discharge.

  • PDF

당뇨병이 없는 농촌지역의 건강한 성인 남녀에서 당화혈색소와 내장지방과의 관계 (Association of Hemoglobin A1c with Visceral Fat Measured by Computed Tomography in Nondiabetic Adults)

  • 한아름;신새론;박성훈;이정미
    • 농촌의학ㆍ지역보건
    • /
    • 제37권4호
    • /
    • pp.215-222
    • /
    • 2012
  • 당화혈색소 5.7%이상에서 6.4%이하인 당뇨전 단계는 당뇨와 심혈관 질환의 위험요소임이 이미 알려져 있다. 최근 미국 당뇨병 학회에서는 당화혈색소를 당뇨의 진단 기준으로 추가하였다. 이러한 배경을 바탕으로 본 연구에서는 농촌 지역 건강한 성인 남녀를 대상으로 당화혈색소와 내장지방과의 관련성을 살펴보았다. 일개 대학병원 건강 검진 수진자 중 건강한 성인 남녀 507명을 연구 대상자로 선정하였다. 연구 대상자에게 설문지를 기입하도록 하고 혈압, BMI, 혈액검사를 측정하였고, 총 복부지방, 내장지방, 피하지방은 CT를 이용하여 측정하였다. 연구 대상자를 남녀로 구분지어 평균값을 비교한 결과 내장지방, 피하지방, 중성지방, 당화혈색소가 유의한 차이를 보였다. 남녀로 구분지어 당화혈색소 5.7%를 기준으로 미만 군과 이상 군으로 분류하고 피하지방과 내장지방 및 혈액검사를 비교해보았다. 이 중 내장지방만이 남녀 모두에서 5.7%이상 군과 미만 군 사이에서 유의한 차이를 보였다. 당화혈색소 5.7%이상 군에서 5.7% 미만 군에 비해 내장지방이 높았다. 전진선택법으로 변수를 선택하여 로지스틱 회귀분석을 한 결과, 비교 위험도 1.007(95% CI1.002~1.012) 으로 복부 지방 중 내장지방이 증가함에 따라 당화혈색소가 약간 증가하는 결과를 관찰하였다. 그러므로 본 연구가 시사하는 바와 같이, 당화혈색소가 5.7% 이상처럼 정상이 아닌 경우에는 당뇨병의 유무와 상관없이 여러 심혈관질환 관련 위험 인자를 조사하여 이에 적절한 치료와 예방이 필요할 것으로 사료된다.

정상인(正常人) 및 당뇨병환자(糖尿病患者)에서의 경구당부하시(經口糖負荷時) 혈중(血中) Insulin과 C-Peptide의 변동(變動) (A Study of the Insulin and the C-Peptide Responses to Oral Glucose Load in Nondiabetic and Diabetic Subjects)

  • 이명철;최성재;김응진;민헌기;고창순
    • 대한핵의학회지
    • /
    • 제11권1호
    • /
    • pp.17-32
    • /
    • 1977
  • The present study was undertaken to evaluate the significance of the insulin and the C-peptide rseponse to oral glucose loads in normal and diabetic subjects and to establish the effects of the obesity. In this study, the authors have measured plasma insulin and C-peptide by means of radioimmunoassay in 10 nonobese normal, 5 obese normal, 13 nonobese moderate diabetic patients, 9 obese moderate diabetic patients and 9 severe diabetic patients. The results obtained were as follows; 1. In 10 nonobese normal subjects, the plasma insulin level at fasting state and at 30, 60, 90, and 120 min after oral glucose loads were $15.7{\pm}3.4,\;48.3{\pm}9.8,\;40.4{\pm}6.7,\;37.4{\pm}6.5\;and\;26.0{\pm}4.2uU/ml(Mean{\pm}S.E.)$ and C-peptide were $1.9{\pm}0.3,\;3.9{\pm}0.6,\;6.3{\pm}0.6,\;5.7{\pm}0.5\;and\;4.0{\pm}0.5ng/ml$. The change of C-peptide was found to go almost parallel with that of insulin and the insulin value reaches to the highest level at 30 min whereas C-peptide reaches to its peak at 60min. 2. The plasma insulin level in 5 obese normal subjects were $38.9{\pm}12.3,\;59.5{\pm}12.3,\;59.2{\pm}17.1,\;56.1{\pm}20.0\;and\;48.4{\pm}17.2uU/ml$ and the C-peptide were $5.5{\pm}0.4,\;6.8{\pm}0.5,\;7.9{\pm}0.8,\;7.9{\pm}0.8\;and\;7.8{\pm}2.0ng/ml$. The insulin response appeared to be greater than nonobese normal subjects. 3. In 13 nonobese moderate diabetic patients, the plasma insulin levels were $27.1{\pm}4.9,\;44.1{\pm}6.0,\;37.3{\pm}6.6,\;35.5{\pm}8.1\;and\;34.7{\pm}10.7uU/ml$ and the C-peptide levels were $2.7{\pm}0.4,\;4.9{\pm}0.7,\;6.5{\pm}0.5,\;7.0{\pm}0.3\;and\;6.7{\pm}1.0ng/ml$. There was little significance compared to nonobese normal groups but delayed pattern is noted. 4. In 9 obese moderated diabetic patients, the plasma insulin levels were $22.1{\pm}7.9,\;80.0{\pm}19.3,\;108.0{\pm}27.0,\;62.0{\pm}17.6\;and\;55.5{\pm}10.1uU/ml$ and the C-peptide levels were $5.2{\pm}0.4,\;8.0{\pm}1.0,\;10.4{\pm}1.6,\;10.4{\pm}1.7\;and\;10.1{\pm}1.0ng/ml$ and its response was also greater than that of nonobese moderate diabetic patients. 5. The plasma insulin concentrations in 9 severe diabetic subjects were $8.0{\pm}3.8,\;12.1{\pm}3.5,\;16.8{\pm}4.6,\;19.6{\pm}5.2\;and\;15.0{\pm}5.0uU/ml$ and the C-peptide levels were $1.6{\pm}0.3,\;2.4{\pm}0.4,\;4.1{\pm}0.6,\;4.0{\pm}0.8\;and\;4.5{\pm}0.7ng/ml$ and the insulin and C-peptide responses were markedly reduced in severe diabetic groups. 6. There were-significant differences between each groups of patients on the magnitude of total insulin or C-peptide areas, the insulinogenic index and the C-peptide index.

  • PDF